Vanta Bioscience Reports H1 FY27 Results with Turnaround to Consolidated Net Profit
Vanta Bioscience Ltd 路 Financial Result 路 14 Nov 2026, 12:31 am
Vanta Bioscience Reports H1 FY27 Results with Turnaround to Consolidated Net Profit Vanta Bioscience reported consolidated revenue from operations of Rs. 105.74 lakhs for the half year ended 30th Sep'26, up 250.36% YoY from Rs. 30.18 lakhs in the prior-year period. Total consolidated income stood at Rs. 109.95 lakhs. The group achieved a turnaround with a consolidated net profit after tax of Rs. 5.14 lakhs, compared to a net loss of Rs. 181.89 lakhs in H1 FY26. Consolidated basic and diluted EPS came in at Rs. 0.07 versus negative Rs. 2.56 YoY.
Original exchange filing (PDF)
More announcements from Vanta Bioscience Ltd
- Outcome of Board Meeting 路 14 Nov 2026
- Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting .... 路 13 Nov 2026
- Vanta Bioscience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Intimation of Board Meeting .... 路 13 Nov 2026
- Submission of AGM Proceedings, Voting Results and Scrutinizers Report for the 10th Annual General Meeting 路 01 Oct 2026
- Submission of AGM Proceedings, Voting Results and Scrutinizer''s Report for the 10th AGM 路 01 Oct 2026
- Outcome of Board Meeting held on 05.09.2026 - 10th AGM to be held on 30.09.2026 路 05 Sept 2026
- Audited standalone and consolidated Financial Results for the half year and financial year ended March 31, 2026 路 31 May 2026
- Outcome of the Board Meeting held on 30.05.2026 路 31 May 2026
